Acumen Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
21 Jul 23 | BuyUS$39,999,998 | RA Capital Management, L.P. | Company | 5,161,290 | US$7.75 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 171,984 | 0.286% |
General Public | 7,936,513 | 13.2% |
Individual Insiders | 9,278,533 | 15.4% |
VC/PE Firms | 18,349,138 | 30.5% |
Institutions | 24,343,610 | 40.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 46.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
14,932,063 | US$48.1m | 0% | 0.66% | |||
3,451,152 | US$11.1m | 0% | no data | |||
3,417,075 | US$11.0m | 0% | 3.31% | |||
3,327,809 | US$10.7m | 18.5% | no data | |||
2,547,143 | US$8.2m | 0% | no data | |||
2,538,162 | US$8.2m | -1.66% | no data | |||
2,300,059 | US$7.4m | -18.2% | 0.21% | |||
1,895,023 | US$6.1m | 0% | 0.22% | |||
1,839,552 | US$5.9m | -0.92% | no data | |||
1,725,576 | US$5.6m | 0% | 100.0% | |||
1,725,576 | US$5.6m | 0% | 100.0% | |||
1,628,510 | US$5.2m | 0% | 0.98% | |||
1,495,284 | US$4.8m | -12.9% | no data | |||
733,203 | US$2.4m | 19.5% | 0.02% | |||
657,985 | US$2.1m | 0% | no data | |||
604,620 | US$1.9m | 3,500% | no data | |||
603,497 | US$1.9m | 20.7% | 0.27% | |||
564,400 | US$1.8m | 7.5% | 0.02% | |||
561,542 | US$1.8m | -13% | 0.01% | |||
521,697 | US$1.7m | 193% | no data | |||
479,149 | US$1.5m | 0.07% | 0.01% | |||
315,265 | US$1.0m | 0% | 0.26% | |||
303,919 | US$978.6k | 0% | no data | |||
264,603 | US$852.0k | 0% | no data | |||
248,095 | US$798.9k | -57.5% | no data |